Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)-2026/4/1

Scientific guideline: Draft reflection paper on the application of Article 40(5) of Regulation (EU) 2019/6 for certain categories of variations-2022/11/24

Guidance for Industry - Migraine: Developing Drugs for Preventive Treatment Drug Trials Snapshot: PYRUKYND-2023/6/1

国家药监局综合司关于“可降解膨胀止血绵”类产品分类界定的通知-2023/12/6

Document: European Medicines Agency Write PMS API implementation Guide-2025/1/21

Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure-2025/2/24

Document: Scientific advice and protocol assistance adopted during the CHMP meeting 24-27 March 2025-2025/4/1

Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Draft Guidance for Industry-2025/5/2

Document: Superseded opinion of the HMPC on a Community herbal monograph on Zingiber officinale Roscoe, rhizoma-2025/6/19

Document: Guideline on the pharmaceutical quality of inhalation and nasal medicinal products - Revision 1-2025/7/24